M. Dilber

发表

Visualization of 5T33 myeloma cells in the C57BL/KaLwRij mouse: establishment of a new syngeneic murine model of multiple myeloma.

E. Alici, Kyriakos V Konstantinidis, A. Aints, 2004, Experimental hematology.

Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22

A. Phelan, A. Aints, M. Dilber, 1999, Gene Therapy.

Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components.

H. Ljunggren, G. Gahrton, H. Nahi, 2008, Blood.

Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo.

C. Naus, G. Gahrton, M. Dilber, 1997, Cancer research.

The derivation of clinical‐grade human embryonic stem cell lines

M. Dilber, O. Hovatta, H. Skottman, 2006, FEBS letters.

Retroviral‐mediated gene transfer into human bone marrow stromal cells: Studies of efficiency and in vivo survival in SCID mice

G. Gahrton, M. Dilber, H. Garoff, 1995, European journal of haematology.

Suicide gene therapy: possible applications in haematopoietic disorders

G. Gahrton, M. Dilber, M. S. Dilber, 2001, Journal of internal medicine.

Proximal promoter of the murine syndecan‐1 gene is not sufficient for the developmental pattern of syndecan expression in B lineage cells

G. Gahrton, P. Jaakkola, M. Jalkanen, 2001, American journal of hematology.

Suicide gene therapy for plasma cell tumors.

G. Gahrton, M. Dilber, B. Christensson, 1996, Blood.

Targeting IL-2 to the endoplasmic reticulum confines autocrine growth stimulation to NK-92 cells.

H. Ljunggren, E. Alici, Kyriakos V Konstantinidis, 2005, Experimental hematology.

Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a phase I clinical study.

E. Kimby, H. Ljunggren, K. Cederlund, 2009, Immunotherapy.

OuaSelect, a novel ouabain-resistant human marker gene that allows efficient cell selection within 48 h

C. Unger, A. Aints, M. Dilber, 2007, Gene Therapy.

Retroviral-mediated gene transfer of CD34-enriched bone marrow and peripheral blood cells during autologous stem cell transplantation for multiple myeloma.

P. Ljungman, M. Dilber, B. Björkstrand, 1994, Human gene therapy.

A murine model of acute myeloid leukemia with Evi1 overexpression and autocrine stimulation by an intracellular form of GM-CSF in DA-3 cells

G. Gahrton, C. I. Smith, M. Dilber, 2016, Leukemia & lymphoma.

Efficient gene transfer into primary human natural killer cells by retroviral transduction.

H. Ljunggren, E. Alici, Kyriakos V Konstantinidis, 2005, Experimental hematology.

Differentiation of human embryonic stem cells into osteogenic or hematopoietic lineages: A dose‐dependent effect of osterix over‐expression

L. Ährlund‐Richter, M. Wendel, M. Dilber, 2009, Journal of cellular physiology.

Anti-myeloma activity of endogenous and adoptively transferred activated natural killer cells in experimental multiple myeloma model.

H. Ljunggren, G. Gahrton, E. Alici, 2007, Experimental hematology.

Choosing CCR5 or Rev siRNA in HIV-1

M. Dilber, B. Wahrén, B. Christensson, 2003, Nature Biotechnology.

Gap junction-mediated bystander effect in primary cultures of human malignant gliomas with recombinant expression of the HSVtk gene.

T. Ekström, O. Ammerpohl, A. Aints, 2003, Experimental cell research.

Long-term follow-up of gene-marked CD34+ cells after autologous stem cell transplantation for multiple myeloma

G. Gahrton, E. Alici, A. Aints, 2007, Cancer Gene Therapy.

Gene marking and gene therapy in multiple myeloma.

G. Gahrton, P. Ljungman, M. Dilber, 1998, Advances in experimental medicine and biology.

Good manufacturing practice and clinical-grade human embryonic stem cell lines.

Heli Skottman, Outi Hovatta, M. Dilber, 2008, Human molecular genetics.

NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy

H. Ljunggren, E. Alici, C. Fauriat, 2008, Cancer Immunology, Immunotherapy.

Lentiviral‐Mediated HoxB4 Expression in Human Embryonic Stem Cells Initiates Early Hematopoiesis in a Dose‐Dependent Manner but Does Not Promote Myeloid Differentiation

L. Ährlund‐Richter, M. Wendel, A. Aints, 2008, Stem cells.

Genetically Modified Autoactivated Cells Expressing Intracellular Forms of GM‐CSF as a Model for Regulated Administration of Cytokines

G. Gahrton, M. Dilber, B. Christensson, 2005, Scandinavian journal of immunology.

Basic fibroblast growth factor increases retroviral-mediated gene transfer into human hematopoietic peripheral blood progenitor cells.

G. Gahrton, M. Dilber, B. Björkstrand, 1994, Experimental hematology.

Enhanced ouabain resistance gene as a eukaryotic selection marker.

A. Aints, M. Dilber, R. Belusa, 2002, Human gene therapy.

The prognostic significance of 8p21 deletion in multiple myeloma

G. Gahrton, M. Jansson, H. Nahi, 2008, British journal of haematology.

Expression and release of stable and active forms of murine granulocyte-macrophage colony-stimulating factor (mGM-CSF) targeted to different subcellular compartments.

G. Gahrton, M. Dilber, B. Christensson, 2001, Cytokine.

TK.007: A novel, codon-optimized HSVtk(A168H) mutant for suicide gene therapy.

G. Gahrton, E. Alici, B. Fehse, 2010, Human gene therapy.

M. Remberger, M. Dilber, B. Lönnqvist, 1999, Bone Marrow Transplantation.

Evaluation of ex vivo expanded human NK cells on antileukemia activity in SCID-beige mice

H. Ljunggren, M. Dilber, B. Christensson, 2006, Leukemia.

Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy

E. Kimby, H. Ljunggren, M. Dilber, 2003, Leukemia.

Suicide genes and bystander killing: local and distant effects

M. Dilber, C. Smith, 1997, Gene Therapy.